Jun 01, 2020
Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19
Mar 20, 2020
Air Seychelles takes delivery of Pti Merl Dezil
Mar 05, 2020
Phoenix Tower International acquires 197 wireless communication tower sites located throughout the United States from Tower Ventures
Jan 22, 2020
Phillips & Temro Industries Celebrates 100 Years of Excellence in Providing Custom-Engineered Thermal Systems and Electrical Solutions
Dec 23, 2019
Phoenix Tower International enters agreements to acquire 1,408 towers in Ecuador and 1,046 towers in Colombia from Telefonica
Dec 16, 2019
VIRTEX Acquires Precision Technology Inc. (PTI)
Aug 07, 2019
Proteostasis Therapeutics Reports Second Quarter 2019 Financial Results and Provides Corporate Update
May 08, 2019
Proteostasis Therapeutics Reports First Quarter 2019 Financial Results and Provides Corporate Update
Feb 15, 2019
Phoenix Tower International expands footprint in South America with acquisition of 600 wireless communication tower sites from Trilogy in Bolivia
Jan 08, 2019
CompTIA Expands Public Sector Practice with Addition of Public Technology Institute (PTI)
Dec 28, 2018
Phoenix Tower International acquires Syscom Telecom, adding over 80,000 marketable small cell wireless communication sites in the United States
Dec 28, 2018
Phoenix Tower International Closes $200mn Loan Facility with Goldman Sachs to Finance Further Expansion
Dec 13, 2018
Innuvo Partners with PTI Security to Fortify Self-Storage Security Solutions
Oct 17, 2018
Proteostasis Therapeutics Announces Positive Preliminary Results from Proprietary Doublet in Cystic Fibrosis Patients
Sep 28, 2018
Digicel Completes Sale and Leaseback Agreement With Phoenix Tower International
Aug 02, 2018
PTI Security Partners With ZAPT On-Demand Moving & Delivery, Consumers and Storage Operators Win
Jul 30, 2018
Phoenix Tower International enters agreement to purchase 1,049 telecommunication assets in the Dominican Republic
Jun 06, 2018
Proteostasis Announces Positive Data from Ongoing Phase 1 Study of PTI-801 in Cystic Fibrosis Patients on Background Orkambi® Therapy
Jun 01, 2018
Proteostasis Announces Presentations at the 41st European Cystic Fibrosis Society Conference
May 08, 2018
Proteostasis Announces Formation of Independent Steering Committee of Leading Experts to Advise on the Global Phase 3 Clinical Development Program for PTI-428 in Cystic Fibrosis